The E3 ubiquitin ligases involved in TAK1 signaling and regulation of NAFLD are TRIM31, TRIM16, TRIM8, TRAF6, and TRAF3, and the DUBs are USP4, USP18, USP13, and CYLD (Figure 1). Here, MAP3K7 is linked to metabolic dysfunction-associated steatotic liver disease.